FTC gives Hologic early greenlight for $580M takeover of Third Wave
The Federal Trade Commission (FTC) Tuesday granted early termination of the waiting period related to Hologic’s previously announced tender offer for all of the outstanding shares of the common stock of Third Wave Technologies.
The early termination of the waiting period, under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, satisfies the conditions to the tender offer related to the expiration or termination of any applicable waiting periods under the HSR Act and other state and foreign regulatory laws relating to the restraint of trade or lessening of competition, according to the Bedford, Mass.-based Hologic.
The company said its tender offer, which is approximated at $580 million, remains subject to certain other conditions described in the offer to purchase.
As previously announced, Hologic commenced a tender offer on June 18 for all of the outstanding shares of Third Wave common stock for $11.25 per share in cash. The tender offer is scheduled to expire at 12:00 midnight, ET, on July 16.
The early termination of the waiting period, under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, satisfies the conditions to the tender offer related to the expiration or termination of any applicable waiting periods under the HSR Act and other state and foreign regulatory laws relating to the restraint of trade or lessening of competition, according to the Bedford, Mass.-based Hologic.
The company said its tender offer, which is approximated at $580 million, remains subject to certain other conditions described in the offer to purchase.
As previously announced, Hologic commenced a tender offer on June 18 for all of the outstanding shares of Third Wave common stock for $11.25 per share in cash. The tender offer is scheduled to expire at 12:00 midnight, ET, on July 16.